-
1
-
-
16644385765
-
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial
-
Urba S.G., Moon J., Giri P.G., Adelstein D.J., Hanna E., Yoo G.H., et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 23 (2005) 88-95
-
(2005)
J Clin Oncol
, vol.23
, pp. 88-95
-
-
Urba, S.G.1
Moon, J.2
Giri, P.G.3
Adelstein, D.J.4
Hanna, E.5
Yoo, G.H.6
-
2
-
-
4243163197
-
Concomitant radiochemotherapy vs. radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study
-
Fountzilas G., Ciuleanu E., Dafni U., Plataniotis G., Kalogera-Fountzila A., Samantas E., et al. Concomitant radiochemotherapy vs. radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study. Med Oncol 21 (2004) 95-107
-
(2004)
Med Oncol
, vol.21
, pp. 95-107
-
-
Fountzilas, G.1
Ciuleanu, E.2
Dafni, U.3
Plataniotis, G.4
Kalogera-Fountzila, A.5
Samantas, E.6
-
3
-
-
18944395784
-
State-of-the-art management of locally advanced head and neck cancer
-
Seiwert T.Y., and Cohen EEW. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92 (2005) 1341-1348
-
(2005)
Br J Cancer
, vol.92
, pp. 1341-1348
-
-
Seiwert, T.Y.1
Cohen EEW2
-
4
-
-
10744229941
-
Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
-
Katori H., Tsukuda M., Mochimatsu I., Ishitoya J., Kawai S., Mikami Y., et al. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 90 (2004) 348-352
-
(2004)
Br J Cancer
, vol.90
, pp. 348-352
-
-
Katori, H.1
Tsukuda, M.2
Mochimatsu, I.3
Ishitoya, J.4
Kawai, S.5
Mikami, Y.6
-
5
-
-
33646336936
-
Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx
-
Taguchi T., Tsukuda M., Mikami Y., Matsuda H., Horiuchi C., Yoshida T., et al. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Oto-Laryngol 126 (2006) 408-413
-
(2006)
Acta Oto-Laryngol
, vol.126
, pp. 408-413
-
-
Taguchi, T.1
Tsukuda, M.2
Mikami, Y.3
Matsuda, H.4
Horiuchi, C.5
Yoshida, T.6
-
8
-
-
0028852938
-
An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer
-
Munro A.J. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71 (1995) 83-91
-
(1995)
Br J Cancer
, vol.71
, pp. 83-91
-
-
Munro, A.J.1
-
9
-
-
0029868441
-
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials
-
El-Sayed S., and Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14 (1996) 838-847
-
(1996)
J Clin Oncol
, vol.14
, pp. 838-847
-
-
El-Sayed, S.1
Nelson, N.2
-
10
-
-
0034681783
-
Chemotherapy added to locoragional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACHNC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer
-
Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoragional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACHNC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
-
(2000)
Lancet
, vol.355
, pp. 949-955
-
-
Pignon, J.P.1
Bourhis, J.2
Domenge, C.3
Designe L4
-
11
-
-
0025807080
-
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
-
The Department of Veterans Affairs Laryngeal Cancer Study Group
-
The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
-
(1991)
N Engl J Med
, vol.324
, pp. 1685-1690
-
-
-
12
-
-
0036751172
-
Treatment of locally advanced head and neck cancer: historical and critical review
-
Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review. Cancer Cont 9 (2002) 387-399
-
(2002)
Cancer Cont
, vol.9
, pp. 387-399
-
-
Al-Sarraf, M.1
-
13
-
-
20144374145
-
Supradose intra-arterial cisplat;in and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615
-
Robbins K.T., Kumar P., Harris J., McCulloch T., Cmelak A., Sofferman R., et al. Supradose intra-arterial cisplat;in and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 23 (2005) 1447-1454
-
(2005)
J Clin Oncol
, vol.23
, pp. 1447-1454
-
-
Robbins, K.T.1
Kumar, P.2
Harris, J.3
McCulloch, T.4
Cmelak, A.5
Sofferman, R.6
-
14
-
-
33644971314
-
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm
-
Pfister D.G., Su Y.B., Kraus D.H., Wolden S.L., Lis E., Aliff T.B., et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol 24 (2006) 1072-1078
-
(2006)
J Clin Oncol
, vol.24
, pp. 1072-1078
-
-
Pfister, D.G.1
Su, Y.B.2
Kraus, D.H.3
Wolden, S.L.4
Lis, E.5
Aliff, T.B.6
-
15
-
-
20444479101
-
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study
-
Fonseca E., Grau J.J., Sastre J., Garcia-Gomez J.M., Rueda A., Pastor M., et al. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. Eur J Cancer 41 (2005) 1254-1260
-
(2005)
Eur J Cancer
, vol.41
, pp. 1254-1260
-
-
Fonseca, E.1
Grau, J.J.2
Sastre, J.3
Garcia-Gomez, J.M.4
Rueda, A.5
Pastor, M.6
-
16
-
-
0028134726
-
Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck
-
Furukawa S., Tsukuda M., Mochimatsu I., Kokatsu T., Satoh H., and Sakumoto M. Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck. Auris Nasus Larynx 21 (1994) 181-185
-
(1994)
Auris Nasus Larynx
, vol.21
, pp. 181-185
-
-
Furukawa, S.1
Tsukuda, M.2
Mochimatsu, I.3
Kokatsu, T.4
Satoh, H.5
Sakumoto M6
-
17
-
-
0018700143
-
Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism
-
Cadman E., Heimer R., and Davis L. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science 205 (1979) 1135-1157
-
(1979)
Science
, vol.205
, pp. 1135-1157
-
-
Cadman, E.1
Heimer, R.2
Davis L3
-
18
-
-
0019424961
-
The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells
-
Cadman E., Heimer R., and Benz C. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem 256 (1981) 1695-1704
-
(1981)
J Biol Chem
, vol.256
, pp. 1695-1704
-
-
Cadman, E.1
Heimer, R.2
Benz, C.3
-
19
-
-
0019134597
-
Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines
-
Benz C., Schoenberg M., Choti M., and Cadman E. Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. J Clin Invest 66 (1980) 1162-1165
-
(1980)
J Clin Invest
, vol.66
, pp. 1162-1165
-
-
Benz, C.1
Schoenberg, M.2
Choti, M.3
Cadman E4
-
20
-
-
0031783658
-
Docetaxel in head and neck cancer: a review
-
Colevas A.D., and Posner MR. Docetaxel in head and neck cancer: a review. Am J Clin Oncol 21 (1998) 482-486
-
(1998)
Am J Clin Oncol
, vol.21
, pp. 482-486
-
-
Colevas, A.D.1
Posner MR2
-
21
-
-
35349016632
-
Treatment for N2 pyriform sinus cancer
-
(in Japanese)
-
Hoki K., Kawabata K., Nigauri T., Mitani H., Yoshimoto S., Yonekawa H., et al. Treatment for N2 pyriform sinus cancer. Head Neck Cancer 28 (2002) 552-556 (in Japanese)
-
(2002)
Head Neck Cancer
, vol.28
, pp. 552-556
-
-
Hoki, K.1
Kawabata, K.2
Nigauri, T.3
Mitani, H.4
Yoshimoto, S.5
Yonekawa, H.6
-
22
-
-
35348973808
-
Carcinoma of the hypopharynx-analysis of prognostic factors for survival
-
(in Japanese)
-
Mochiki M., Sugawara M., Nakao K., Yuge T., Sakamoto T., and Andou M. Carcinoma of the hypopharynx-analysis of prognostic factors for survival. Head Neck Cancer 29 (2003) 12-22 (in Japanese)
-
(2003)
Head Neck Cancer
, vol.29
, pp. 12-22
-
-
Mochiki, M.1
Sugawara, M.2
Nakao, K.3
Yuge, T.4
Sakamoto, T.5
Andou M6
-
23
-
-
0019822093
-
T4N0M0 glottic cancer: an analysis of dose-time volume factors
-
Harwood A.R., Beale F.A., Cummings B.J., Keane T.J., Payne D., and Rider W.D. T4N0M0 glottic cancer: an analysis of dose-time volume factors. Int J Radiat Oncol Biol Phys 7 (1981) 1507-1512
-
(1981)
Int J Radiat Oncol Biol Phys
, vol.7
, pp. 1507-1512
-
-
Harwood, A.R.1
Beale, F.A.2
Cummings, B.J.3
Keane, T.J.4
Payne, D.5
Rider, W.D.6
-
24
-
-
0024328921
-
Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications
-
Croll G.A., Gerritsen G.J., Tiwari R.M., and Snow GB. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications. Eur J Surg Oncol 15 (1989) 350-356
-
(1989)
Eur J Surg Oncol
, vol.15
, pp. 350-356
-
-
Croll, G.A.1
Gerritsen, G.J.2
Tiwari, R.M.3
Snow GB4
|